Galson Steven K 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Galson Steven K
Director
Transactions
- Award
Common Stock
2024-06-12+6,820→ 36,431 total - Award
Automatic Stock Option Grant
2024-06-12+49,933→ 49,933 totalExercise: $6.30From: 2025-06-12Exp: 2034-06-12→ Common Stock (49,933 underlying)
Holdings
- 21,940(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- [F2]The shares purchased by the reporting person on May 13, 2024 were inadvertently reported as being purchased directly by the reporting person but were actually purchased by the reporting person's trust. The reporting person is a trustee of such trust and the reporting person and members of his family are the sole beneficiaries of the trust. The reporting person is an indirect beneficial owner of the shares held by the trust.
- [F3]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.